Related Experiment Video
Updated: Aug 17, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Verapamil-potassium cardioplegia: a two-year experience with 470 patients
1Department of Surgery, University of Rochester Medical Center, Rochester, New York 14642, USA.
Abstract:
This prospective clinical study in cardiac surgery involves a 2-year experience with verapamil-potassium cardioplegia in 470 patients. Protective benefits, associated with calcium channel blockers during cellular ischemia, have increased their utilization in cardioplegic solutions during open-heart surgery. Analysis of the group includes preoperative, intraoperative, and postoperative variables. Preoperative data encompasses age, previous myocardial infarctions, ejection fraction, cardiac index, and risk factors. Analysis of operative data includes the type of operation performed, anesthetic agents, amount of cardioplegia solution, total peripheral resistance, fluid requirements, cross-clamp time and arrhythmias during reperfusion. In this study, verapamil proved to be a safe and effective additive to standard potassium cardioplegia. Beneficial hemodynamic actions with myocardial preservative and antiarrhythmic effects were demonstrated. Although the "perfect solution" to myocardial preservation remains unknown, because of favorable experimental data and successful clinical trials, the continued use of verapamil-potassium cardioplegia appears justified.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Cardiomyopathy V: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

